Changing the perspective on the 'Cinderella of the cytoskeleton'
E-Mail SETD2 is a protein well known as a chromatin remodeler, one that helps turn genes on or off by modifying histone proteins in the nucleus of the cell. When researchers discovered that SETD2 is mutated or lost in several cancer types, most commonly a type of kidney cancer called clear-cell renal cell carcinoma, all eyes turned toward SETD2 function in the nucleus of the cell to explain these cancers. In 2016, the lab of Dr. Cheryl Walker, director of the Center for Precision Environment...
Source: eurekalert.org